1. Clin Case Rep. 2017 Aug 10;5(9):1536-1541. doi: 10.1002/ccr3.1121. eCollection
 2017 Sep.

T-cell prolymphocytic leukemia and tuberculosis: a puzzling association.

Cervera P(1), Gilhot A(2), Marzac C(3), Féger F(3), Tang R(3), Jaff N(4), Coppo 
P(4)(5)(6)(7).

Author information:
(1)Service d'Anatomopathologie Hôpital Saint-Antoine AP-HP Paris France.
(2)Laboratory of Immunology Groupe Hospitalier Pitié-Salpétrière AP-HP Paris 
France.
(3)Laboratoire d'Hématologie et Immunologie Hôpital Saint-Antoine AP-HP Paris 
France.
(4)Service d'Hématologie Hôpital Saint-Antoine AP-HP Paris France.
(5)Université Pierre et Marie Curie (UPMC Paris 6) Paris France.
(6)Centre de Référence des Microangiopathies Thrombotiques AP-HP Paris France.
(7)Inserm U1170 Institut Gustave Roussy Villejuif France.

T-cell prolymphocytic leukemia can result in severe immune T-cell deficiency. 
Clinicians should be aware of this complication in this rare lymphoid 
malignancy, and opportunistic infections should be ruled out before the use of 
usual immunosuppressive procedures such as alemtuzumab and hematopoietic stem 
cell transplantation.

DOI: 10.1002/ccr3.1121
PMCID: PMC5582236
PMID: 28878921